Ospemifene: less venous thrombosis than other selective estrogen receptor modulators in postmenopausal women with vulvo vaginal atrophy

Menopause. 2020 Aug;27(8):846-847. doi: 10.1097/GME.0000000000001600.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Atrophy / pathology
  • Female
  • Humans
  • Incidence
  • Postmenopause
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / analogs & derivatives
  • Tamoxifen / therapeutic use
  • Venous Thromboembolism*
  • Venous Thrombosis* / drug therapy
  • Vulva / pathology

Substances

  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Ospemifene